12 Comments

  1. Hey Gibbs! Can you look over the biotech stock VXL, Vaxil bio and they’re extreme potential for growth with the recent news on a vaccine patent, closing their bridge financing, and being one of the twelve companies that sat down with trump/pence last week/ also a company on the WHO’s 32 long list for helping discover a vaccine/cure.

  2. The problem is that it is disrupting supply chains.. just because "most" people will survive it NOBODY wants to get it and potentially pass it on to their grandparents, children and already sick people who are at high risk of death. I understand what you are saying but the mortality rate way higher than the common cold. Take the tourist industry off the table it has a massive ripple effect. Oil and gas, hotels, airlines, transportation in general… So I would be a little careful focusing what could be considered a bit insensitive.

  3. Really sad. Gibbs. I feel you Gibb. Everyone is effected by this stupid panic. I was sitting on profits & now it turns into negative bagholders. This sucks. Wish everyone well.

  4. Pray for good news it should be here before april
    The new clinical studies expand the ongoing research into remdesivir, which includes two clinical trials in China’s Hubei province led by the China-Japan Friendship Hospital as well as the recently initiated clinical trial in the United States led by the National Institute of Allergy and Infectious Diseases (NIAID). Gilead has donated drug and provided scientific input for these studies, with results from those in China expected in April.
    They sent it without approval : )
    today

  5. you’re actually a good webmaster. The site loading velocity
    is amazing. It sort of feels that you are doing any distinctive trick.
    Furthermore, The contents are masterpiece. you’ve
    done a excellent task on this matter!

Leave a Reply

Your email address will not be published.